14 Einträge gefunden

1. Syngenic graft-versus-chronic-myeloid-leukemia-effect?

   1. Ocheni, Sunday
   2. Schafhausen, Philippe
   3. Bacher, Ulrike
   4. Fehse, Boris
   5. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
2. Severe aplastic anaemia following leflunomide therapy.

   1. Wüsthof, Mirjam
   2. Smirnova, Anna
   3. Bacher, Ulrike
   4. Kröger, Nicolaus
   5. Zander, Axel R.
   6. Schuch, Gunter
   7. Bokemeyer, Carsten

   2009 - Forschungsinformationssystem des UKE
3. Current status and perspectives of tyrosine kinase inhibitor treatment in the post-transplant period in patients with chronic myeloid leukemia (CML).

   1. Klyuchnikov, Evgeny
   2. Kröger, Nicolaus
   3. Brümmendorf, Tim
   4. Wiedemann, Bettina
   5. Zander, Axel R.
   6. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
4. Outcome of allo-SCT for chronic myelomonocytic leukemia.

   1. Ocheni, Sunday
   2. Kröger, Nicolaus
   3. Zabelina, Tatjana
   4. Zander, Axel R.
   5. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
5. Interactive diagnostics in the indication to allogeneic SCT in AML.

   1. Bacher, Ulrike
   2. Haferlach, C
   3. Schnittger, S
   4. Kern, W
   5. Kröger, Nicolaus
   6. Zander, Axel R.
   7. Haferlach, T

   2009 - Forschungsinformationssystem des UKE
6. Second allogeneic stem cell transplantation in myeloid malignancies.

   1. Hartwig, Maite
   2. Ocheni, Sunday
   3. Asenova, Svetlana
   4. Wiedemann, Bettina
   5. Zabelina, Tatjana
   6. Ayuketang Ayuk, Francis
   7. Kabisch, Hartmut

   2009 - Forschungsinformationssystem des UKE
7. JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation.

   1. Kröger, Nicolaus
   2. Alchalby, Haefaa
   3. Klyuchnikov, Evgeny
   4. Badbaran, Anita
   5. Hildebrandt, York
   6. Ayuketang Ayuk, Francis
   7. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
8. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

   1. Kröger, Nicolaus
   2. Badbaran, Anita
   3. Lioznov, Michael
   4. Schwartz, Sabine
   5. Zeschke, Silke
   6. Hildebrandt, York
   7. Ayuketang Ayuk, Francis

   2009 - Forschungsinformationssystem des UKE
9. Safety of conditioning agents for allogeneic haematopoietic transplantation.

   1. Bacher, Ulrike
   2. Klyuchnikov, Evgeny
   3. Wiedemann, Bettina
   4. Kröger, Nicolaus
   5. Zander, Axel R.

   2009 - Forschungsinformationssystem des UKE
10. Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

    1. Klyuchnikov, Evgeny
    2. Schafhausen, Philippe
    3. Kröger, Nicolaus
    4. Brümmendorf, Tim
    5. Osanmaz, Okay
    6. Asenova, Svetlana
    7. Zabelina, Tatjana

    2009 - Forschungsinformationssystem des UKE
11. Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.

    1. Ocheni, Sunday
    2. Zabelina, Tatjana
    3. Bacher, Ulrike
    4. Ayuketang Ayuk, Francis
    5. Zander, Axel R.
    6. Kröger, Nicolaus

    2009 - Forschungsinformationssystem des UKE
12. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

    1. Bacher, Ulrike
    2. Badbaran, Anita
    3. Fehse, Boris
    4. Zabelina, Tatjana
    5. Zander, Axel R.
    6. Kröger, Nicolaus

    2009 - Forschungsinformationssystem des UKE
13. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

    1. Kröger, Nicolaus
    2. Zabelina, Tatjana
    3. Binder, Thomas
    4. Ayuketang Ayuk, Francis
    5. Bacher, Ulrike
    6. Amtsfeld, Gitta
    7. Lellek, Heinrich

    2009 - Forschungsinformationssystem des UKE
14. Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosis.

    1. Bacher, Ulrike
    2. Asenova, Svetlana
    3. Badbaran, Anita
    4. Zander, Axel R.
    5. Alchalby, Haefaa
    6. Fehse, Boris
    7. Kröger, Nicolaus

    2009 - Forschungsinformationssystem des UKE